Supermarket shelves across the United States are increasingly featuring meals and snacks emblazoned with "GLP-1 Friendly" labels, a direct response to the growing number of Americans turning to obesity medications like Wegovy and Zepbound for weight loss.
However, unlike the popular drugs themselves, these labels lack regulation from the U.S. Food and Drug Administration, prompting dieticians to urge consumers to scrutinise ingredient lists and consult experts on their specific nutritional requirements.
